Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charlie Hospital Semarang Tbk. (RSCH) vs Suparma Tbk. (SPMA) Price & Performance

Charlie Hospital Semarang Tbk.Trade
Suparma Tbk.Trade

Price performance (Past 24H)

Key statistics

Charlie Hospital Semarang Tbk. vs Suparma Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp306 (market cap 821.5B, 38.6K 24h volume), while Suparma Tbk. trades at Rp167 (market cap 874.19B, 6K 24h volume). The key difference: Charlie Hospital Semarang Tbk. and Suparma Tbk. are close in size by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (38.6K versus 6K). Which is the better fit depends on your goals.

RSCHSPMA
Market Cap
821.5B874.19B
Volume
38.6K6K
Lot
38660
Turnover
11.88M997.8K
Average Price
307.87166.3
Value
11.88M997.8K
Indicative Equilibrium Price
312
Indicative Equilibrium Volume
10

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RSCH
View details
SPMA
View details

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH

About Suparma Tbk.

PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.

Read more on SPMA